CLARANOVA SE (CLA.PA)

FR0013426004 - Common Stock

2.65  -0.1 (-3.81%)

Fundamental Rating

3

Overall CLA gets a fundamental rating of 3 out of 10. We evaluated CLA against 96 industry peers in the Software industry. While CLA is still in line with the averages on profitability rating, there are concerns on its financial health. CLA has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
CLA had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -4.01%, CLA is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 21.67%, CLA belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLA is above the industry average of 10.46%.
The 3 year average ROIC (13.37%) for CLA is below the current ROIC(21.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.01%
ROE N/A
ROIC 21.67%
ROA(3y)-1.22%
ROA(5y)-5.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)13.37%
ROIC(5y)10.65%

1.3 Margins

CLA has a Operating Margin (5.13%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLA has grown nicely.
CLA's Gross Margin of 24.64% is on the low side compared to the rest of the industry. CLA is outperformed by 88.10% of its industry peers.
In the last couple of years the Gross Margin of CLA has remained more or less at the same level.
Industry RankSector Rank
OM 5.13%
PM (TTM) N/A
GM 24.64%
OM growth 3Y21.32%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.27%
GM growth 5Y0.82%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
The number of shares outstanding for CLA has been reduced compared to 1 year ago.
Compared to 5 years ago, CLA has more shares outstanding
Compared to 1 year ago, CLA has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that CLA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.08, CLA is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACC3.35
WACC6.47%

2.3 Liquidity

A Current Ratio of 0.64 indicates that CLA may have some problems paying its short term obligations.
CLA has a Current ratio of 0.64. This is amonst the worse of the industry: CLA underperforms 94.05% of its industry peers.
CLA has a Quick Ratio of 0.64. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.52, CLA is doing worse than 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.52

5

3. Growth

3.1 Past

CLA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.30%, which is quite impressive.
CLA shows a small growth in Revenue. In the last year, the Revenue has grown by 7.23%.
Measured over the past years, CLA shows a very strong growth in Revenue. The Revenue has been growing by 25.71% on average per year.
EPS 1Y (TTM)30.3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q60.53%
Revenue 1Y (TTM)7.23%
Revenue growth 3Y7.41%
Revenue growth 5Y25.71%
Revenue growth Q2Q-0.36%

3.2 Future

Based on estimates for the next years, CLA will show a very strong growth in Earnings Per Share. The EPS will grow by 408.74% on average per year.
The Revenue is expected to grow by 3.79% on average over the next years.
EPS Next Y5233.33%
EPS Next 2Y877.53%
EPS Next 3Y408.74%
EPS Next 5YN/A
Revenue Next Year0.31%
Revenue Next 2Y3.08%
Revenue Next 3Y3.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 16.40, CLA is valued correctly.
78.57% of the companies in the same industry are more expensive than CLA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.63, CLA is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 16.4

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaper than 89.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.38

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 408.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y877.53%
EPS Next 3Y408.74%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (2/23/2024, 7:00:00 PM)

2.65

-0.1 (-3.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap150.32M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.4
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.01%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 5.13%
PM (TTM) N/A
GM 24.64%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.64
Quick Ratio 0.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)30.3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y5233.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.23%
Revenue growth 3Y7.41%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y